Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 1/2/2026

Approach to Assessment and Management of Anxiety Disorders

Definition and Classification

  • Anxiety disorders are characterized by excessive, uncontrollable worry about multiple life domains, accompanied by physical symptoms, panic attacks, avoidance behaviors, and social fears that cause significant functional impairment 1
  • Generalized Anxiety Disorder (GAD) is a chronic, pervasive worry about multiple topics beyond cancer or medical concerns, with physical symptoms 2, 1
  • The American College of Cardiology recommends considering anxiety disorders in patients with cardiac conditions, as anxiety can exacerbate cardiac symptoms 1

Severity Stratification and Assessment

  • The GAD-7 score is used to stratify anxiety severity, with scores ranging from 0-21, and a score of 10 or higher indicating moderate-severe anxiety requiring intervention 2
  • The American Psychiatric Association recommends using standardized screening tools, such as the GAD-7, to assess anxiety severity 1
  • A score of 10-14 on the GAD-7 indicates moderate-severe anxiety, while a score of 15-21 indicates severe anxiety 2

Differential Diagnosis and Medical Conditions

  • Thyroid disorders, such as hyperthyroidism, can mimic anxiety symptoms and should be ruled out through laboratory testing 1, 3
  • Cardiac conditions, such as arrhythmias and coronary artery disease, can also contribute to anxiety symptoms 1
  • The American Heart Association recommends considering anxiety disorders in patients with cardiac conditions, as anxiety can exacerbate cardiac symptoms 1

Treatment and Management

  • The American Psychological Association recommends Cognitive Behavioral Therapy (CBT) as the first-line psychotherapy for anxiety disorders, with a large effect size (Hedges g = 1.01) for GAD 2
  • Selective Serotonin Reuptake Inhibitors (SSRIs) are recommended as the first-line pharmacotherapy for anxiety disorders, with sertraline being a preferred SSRI 3
  • The National Institute of Mental Health recommends combining SSRI with CBT for moderate-severe anxiety, as this combination is superior to either alone 3

Referral and Consultation

  • Immediate psychiatric referral is required for patients with suicidal ideation, harm to others, psychosis, or severe agitation 4, 1
  • Referral to psychology/psychiatry is recommended for patients with moderate-severe symptoms, symptoms not responding to initial treatment, or functional impairment 2
  • The American Academy of Pediatrics recommends referring children and adolescents with anxiety disorders to a pediatric psychologist or psychiatrist for diagnosis and treatment 5

Evidence‑Based Screening and Documentation for Anxiety in Nursing‑Identified Patients

Standardized Anxiety Screening Tools

Depression Screening in Patients with Anxiety

Follow‑Up, Rescreening Frequency, and Documentation

REFERENCES